Press Release
iRhythm Technologies Receives Positive National Guidance in First of its Kind Digital Health Pilot with National Institute for Health and Care Excellence
Remote cardiac monitoring service Zio XT has been evaluated and positively recommended by
iRhythm’s Zio XT Service – a patient-friendly ambulatory cardiac monitor supported by deep learning algorithms – has been assessed as part of NICE’s first pilot project to evaluate digital health technologies. Zio XT has been positively recommended by
Published today, the guidance concluded that Zio XT is convenient and easy to wear, with greater patient compliance and improved diagnostic yield (a measure of how many people with cardiac arrhythmias are diagnosed) compared with standard 24-hour Holter monitoring. Clinical evidence showed that patients preferred Zio XT compared to current monitoring practice in the
Commenting on the news,
“Fortunately, services like Zio can help ease this backlog, offering clinically-validated services remotely. Patients are not required to expose themselves to high-risk hospital environments, while staff can still offer the same continued level of care. It’s critical, therefore, that patients have access to these technologies and for clinicians to be able to implement them quickly and easily.”
The guidance, which evaluates new, innovative medical devices and diagnostics, aims to help people in the
iRhythm’s positive recommendation from the
About
iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distil data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201201005522/en/
Media Contacts:
Hotwire for
irhythmuk@hotwireglobal.com
HighwirePR for
irhythm@highwirepr.com
Investor Relations Contact:
investors@irhythmtech.com
Source: